/Gilead%20Sciences%2C%20Inc_%20logo%20and%20vials%20-by%20Melnikov%20Dmitriy%20via%20Shutterstock.jpg)
With a market cap of around $136 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company. The Foster City, California-located company discovers, develops, and commercializes medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer, and inflammation.
Companies worth $10 billion or more are generally described as “large-cap stocks”, and Gilead Sciences fits this criterion perfectly. The company continues to expand its oncology pipeline through strategic acquisitions and partnerships, while maintaining a strong commitment to scientific research and global health impact.